Altre lingue Recordati

Azioni

Mercato chiuso - Borsa Italiana Altri mercati azionari 17:45:00 18/07/2025			Variaz. 5gg	Var. 1 gen.
52,40 ^EUR	-0,10%		-3,76%	+3,56%

18/07	AGENDA - Italia fino al 31 agosto	RE
16/07	Mercato dei future in rosso, cautela per dazi	AN

DIARY - Italy to Aug. 31	18/07
DIARY - Italy to Aug. 31	15/07
DIARY - Italy to Aug. 31	11/07
DIARY - Italy to Aug. 31	08/07
Faute de carotte, le bâton fait son retour	08/07
Avis d'analystes du jour : nouveaux suivis sur Accor et Galderma, ArgenX relevé et Arkema dégradé	08/07
DIARY - Italy to Aug. 31	27/06
RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal	25/06
Amarin Signs Licensing Deal With Recordati for Vazkepa in Europe; Shares Rise	24/06
Recordati, Amarin Sign Licensing, Supply Deal for Cardiovascular Drug Vazkepa in Europe	24/06
Amarin Signs Licensing Deal With Recordati for Vazkepa in Europe	24/06
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE	24/06
DIARY - Italy to July 31	24/06
DIARY - Italy to July 31	20/06
DIARY - Italy to July 31	17/06
DIARY - Italy to July 31	10/06
DIARY - Italy to July 31	06/06
Les actions en mouvement : une OPA de plus pour l'énergie renouvelable française	06/06
DIARY - Italy to July 31	03/06
DIARY - Italy to July 31	30/05
EU Issues Positive Opinion for Recordati's Maple Syrup Urine Disease Drug	23/05
RBC Ups Recordati's Price Target Post-Q1 Results	23/05
Italy - Factors to watch on May 19	19/05
Recordati : First Quarter Report 2025	12/05
Recordati S.p.A. Provides Earnings Guidance for the Financial Year 2025	08/05

Non ci sono risultati per questa ricerca